new glp 1 gip drug What are GLP-1 and GIP? Dual-action explained

GLP 1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology's annual meeting. 320 AMA 64: New insights on GLP 1 agonists (Ozempic, Wegovy, Mounjaro) efficacy, benefits, risks, and considerations in the rapidly evolving weight loss drug landscape Peter Attia Thinking about GLP 1 options for weight management? There are several popular medications, including semaglutide and tirzepatide based treatments, each with different characteristics and potential outcomes. Treatment plans are always personalized and Current Insights, Advantages and Challenges of Small Molecule Glucagon like Peptide 1 Receptor Agonists: A Scoping Review Published in Journal of Brown Hospital Medicine Bariatric Surgery Vs. GLP 1: Which Weight Loss Option Fits You? Do GLP 1 Agonists Cause Thyroid Cancer (Wegovy, Saxenda, Etc.)